| Serial Number | 98476104 |
| Word Mark | XAIRA |
| Filing Date | Friday, March 29, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, March 3, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical therapeutics and medical therapeutics for treating indications and co-morbidities underlying immune-mediated inflammatory diseases, namely, pharmaceutical preparations for treating immunological diseases, cardiometabolic diseases, infectious diseases, and oncological diseases |
| Goods and Services | Pharmaceutical research and development services using artificial intelligence and machine learning; Scientific and medical research in the field of pharmaceutical development using artificial intelligence and machine learning; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical medicines; Drug development and discovery |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | XAIRA THERAPEUTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SAN FRANCISCO, CA 94108 |
| Party Name | Orion Medicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94108 |
| Event Date | Event Description |
| Sunday, September 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 10, 2024 | ASSIGNED TO EXAMINER |
| Thursday, October 10, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, March 30, 2024 | NEW APPLICATION ENTERED |
| Thursday, June 20, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, October 10, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, October 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 8, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, January 8, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, January 8, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, January 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 15, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, January 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 16, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, February 19, 2025 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, February 19, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, February 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 3, 2025 | ASSIGNED TO LIE |
| Wednesday, February 19, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |